Publishers

Need unique free news content for your site customized to your audience?

Let's Discuss

PRESS RELEASE
By: InvestorBrandNetwork (IBN)
August 27, 2024

Lexaria (NASDAQ: LEXX) Validates Tech’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released findings from its applied research program that sought to evaluate the mode of action facets of its patented DehydraTECH(TM) technology and the glucagon-like peptide 1 (“GLP-1”) drug, semaglutide. The program was conducted in conjunction with the National Research Council of Canada (“NRC”), […]

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This press release is distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Lexaria (NASDAQ: LEXX) Validates Tech’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market.

{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.